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The exchanged EF-hands in calmodulin and
troponin C chimeras impair the Ca2+-induced
hydrophobicity and alter the interaction with
Orai1: a spectroscopic, thermodynamic and kinetic
study
Drake Jensen1, Nicole Reynolds1, Ya-Ping Yang3, Shubha Shakya1, Zhi-Qiang Wang2, Dennis J Stuehr3
and Chin-Chuan Wei1*

Abstract
Background: Calmodulin (CaM) plays an important role in Ca2+-dependent signal transduction. Ca2+ binding to
CaM triggers a conformational change, forming a hydrophobic patch that is important for target protein recognition.
CaM regulates a Ca2+-dependent inactivation process in store-operated Ca2+ entry, by interacting Orai1. To understand
the relationship between Ca2+-induced hydrophobicity and CaM/Orai interaction, chimera proteins constructed by
exchanging EF-hands of CaM with those of Troponin C (TnC) are used as an informative probe to better understand
the functionality of each EF-hand.
Results: ANS was used to assess the context of the induced hydrophobic surface on CaM and chimeras upon Ca2+
binding. The exchanged EF-hands from TnC to CaM resulted in reduced hydrophobicity compared with wild-type CaM.
ANS lifetime measurements indicated that there are two types of ANS molecules with rather distinct fluorescence
lifetimes, each specifically corresponding to one lobe of CaM or chimeras. Thermodynamic studies indicated the
interaction between CaM and a 24-residue peptide corresponding to the CaM-binding domain of Orail1 (Orai-CMBD) is
a 1:2 CaM/Orai-CMBD binding, in which each peptide binding yields a similar enthalpy change (ΔH = −5.02 ± 0.13 kcal/
mol) and binding affinity (Ka = 8.92 ± 1.03 × 105 M−1). With the exchanged EF1 and EF2, the resulting chimeras noted as
CaM(1TnC) and CaM(2TnC), displayed a two sequential binding mode with a one-order weaker binding affinity and
lower ΔH than that of CaM, while CaM(3TnC) and CaM(4TnC) had similar binding thermodynamics as CaM. The
dissociation rate constant for CaM/Orai-CMBD was determined to be 1.41 ± 0.08 s−1 by rapid kinetics. Stern-Volmer plots
of Orai-CMBD Trp76 indicated that the residue is located in a very hydrophobic environment but becomes more
solvent accessible when EF1 and EF2 were exchanged.
Conclusions: Using ANS dye to assess induced hydrophobicity showed that exchanging EFs for all Ca2+-bound
chimeras impaired ANS fluorescence and/or binding affinity, consistent with general concepts about the inadequacy of
hydrophobic exposure for chimeras. However, such ANS responses exhibited no correlation with the ability to interact
with Orai-CMBD. Here, the model of 1:2 binding stoichiometry of CaM/Orai-CMBD established in solution supports the
already published crystal structure.
Keywords: EF-hand, Calcium binding, Calmodulin, Troponin C, Orai, ANS, Isothermal titration calorimetry, Fluorescence,
Kinetics
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Background
Calmodulin (CaM) is a small, acidic protein with 148 amino
acids, which plays important roles in Ca2+-dependent signal
transduction in eukaryotes. There are a number of CaM
target molecules that have been identified, including, to
name a few, protein kinase, protein phosphatase, nitric
oxide synthase, tRNA, Ca2+ pump, and proteins involved in motility and T-cell activation [1]. CaM is a
Ca2+ sensor protein in non-muscle cells, which binds
four Ca2+ ions through its self-contained four Ca2+
binding helix-loop-helix structures called EF-hands
(EFs). The structure of CaM is arranged into two separated globular lobes, each containing a tandem pair of
EFs, with a flexible tether in between. Ca2+-free CaM
adopts a so-called closed structure, in which the two
lobes come in close proximity of each other by burying
most of their hydrophobic residues. Ca2+ binding to
CaM triggers a major conformational change to form
an extended dumbbell-shaped structure, linked by a
solvent-exposed, rigid helical structure in x-ray crystallography [2-4] but an un-structural linker in NMR [5],
suggesting both structures may coexist in solution to
facilitate target complexation.
The mechanism for CaM to recognize its target molecules is primarily through strong hydrophobic interactions, in which Ca2+ binding to CaM exposes its
hydrophobic patch, allowing CaM to interact with the
CaM-binding domain (CMBD) of a target molecule
followed by enzyme activation. A CMBD typically is
comprised of 15–35 amino acids with high propensity
for helix formation, which shows an un-structural conformation in solution but forms an α helix when complexed with CaM. The CMBD sequences are considerably
divergent. There are several structures of CaM/CMBD
complexes that have been determined, including those
that fall under the category of the well-documented canonical model. In this model, each lobe of CaM interacts
with the different ends of a CMBD peptide in a sequential
manner; first binding to the C-terminal lobe followed by
the N-terminal lobe [6,7]. To achieve this, CaM’s helix
linker is disrupted and extended, forcing the structure
to “collapse” to grip the peptide [8]. Despite the overall
structural change, NMR reveals that there is no significant conformational change within each lobe between
the uncomplexed and complexed states [9]. Classic examples of this canonical binding include CaM/M13 and
CaM/CaMKII. Alternatively, other CaM/CMBD complexes have been observed in a non-canonical manner,
in which CaM binds target CMBDs with a 1:1, 1:2 or
2:2 mode (for review, see ref. [10]). Despite that the
current understanding for recognition allows one to
predict the possible CMBD sequences in target enzymes or proteins assisted with the CaM target database [11], the mode of CaM/CMBD recognition still
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remains to be elucidated only by experimental approaches, indicating that the hydrodynamic properties
of CaM and its associated physiochemical properties
are not well understood. Therefore, there is still a need
to understand the structural basis of the interaction between CaM and its target proteins. An advance in this
knowledge will eventually lead to a better understanding of CaM’s diverse regulatory functions.
In the past, chimeras of CaM and Troponin C (TnC)
have been utilized to help elucidate the binding mechanism to their target proteins. CaM and TnC share only
50–70% homology at the amino acid level but they possess striking structural similarities, as shown in the crystal structures of CaM and skeletal TnC (sTnC). Both
CaM and TnC contain four EFs but have an opposite effect in the activation of target enzymes. For example,
TnC can neither bind to nor activate nNOS [12] and has
a very low affinity for Ca2+-ATPase [13]. Given the
structural similarities and functional differences of CaM
and TnC, chimera proteins, in which the domains
containing EFs of CaM are exchanged with the corresponding EFs of TnC, and vice versa, allow for the investigation of the functionality of each specific protein. For
example, chimeras of CaM, where each includes one of
four domains (either the 1st EF-hand (EF1), EF2, EF3 or
EF4) from TnC have been constructed, including CaM
(1TnC) (domain 1 of TnC and domains 2, 3, and 4 of
CaM), CaM(2TnC), CaM(3TnC), and CaM(4TnC), as
well as other multiple-domain exchange chimeras. These
chimeras have been used in the studies of CaM/NOS
[12,14,15] and CaM/Ca2+-ATPase interactions [13]. It is
assumed that these chimeras adopt a similar structure as
CaM, and therefore interact with CMBDs similarly.
Thus, the change of functionality, such as enzyme activation, can be explained mainly by the lack of the association of specific elements in the chimeras (due to the
subtle sequence differences and/or side chain packing)
and specific domains in the target macromolecules. In
some cases, the failure of stimulating enzymatic activation is explained by the lack of complex formation due
to the exchanged domains [16]. However, whether or
not such exchanged EFs have an impact on chimera protein structure, including hydrophobic exposure, as well
as CMBD interactions, has yet to be addressed. Because
the Ca2+-induced hydrophobicity of CaM is generally
believed to be important for its ability to recognize
CMBDs, here, through spectroscopy and calorimetry, we
first utilized the ANS fluorescent probe to assess the extent of hydrophobicity and structural change of the four
chimera proteins upon Ca2+ binding. The sequences of
the constructs from human CaM (hCaM) and cardiac
TnC (cTnC) are summarized in Figure 1. Notable sequence differences among the chimeras include 1) CaM
(1TnC) contains additional N-terminal residues and its
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Figure 1 Sequence alignment of hCaM, cTnC and chimeras. Sequence alignment was performed with ClustalW. Residues are colored coded
in terms of amino acid properties where green are hydrophobic, blue are polar/uncharged, black are positively charged, red are negatively
charged and brown are aromatic. The four, 12-residue EF-hand Ca2+ binding loops are depicted in bold and underlined. The corresponding
sequences from cTnC added to create the individual chimeras are outlined with boxes.

EF1 is non-canonical in that it does not bind Ca2+, and
2) CaM(2TnC) has three extra residues in its central
helix. Besides the sequence difference, TnC also has different Ca2+ binding properties. TnC’s EF4 has a one
order higher Ca2+ affinity than that of CaM, and its second helix of EF2 (i.e. helix D) is oriented differently
compared to that of CaM.
Our laboratory has long interests in the role of STIM
and Orai in store-operated Ca2+ entry (SOCE). STIM is
an ER-membrane bound Ca2+ sensor protein within the
ER lumen, which forms as a monomer and oligomer in
high and low Ca2+ concentrations, respectively. When
Ca2+ is depleted in the ER lumen, a transient structure
from the STIM aggregate formed near the plasma membrane surface activates the Orai Ca2+ channel protein,
leading to Ca2+ influx [17,18]. The Ca2+ influx is immediately inhibited by a Ca2+-dependent inactivation (CDI)
process, mainly through the interaction of CaM and the
CMBD of Orai [19]. Here, we studied the interaction of
CaM with a peptide corresponding to the CMBD of

Orai1 (Orai-CMBD) and further extended the studies to
the chimera proteins themselves. Given the fundamental
differences between CaM and TnC, we anticipate that
these chimeras will serve as an informative probe to better understand the interaction between CaM and OraiCMBD and therefore, could be used to extend to studies
using the whole length of the Orai channel protein as
well as to other CaM/CMBD systems. During our
characterization, an excellent work published by Liu et al.
showed that CaM binds to Orai’s CMBD in an unusual 1:2
open conformation mode [20]. Thus, we rationalized our
experimental data to accommodate their model.

Results and discussion
In physiological conditions, the bulk concentration of
Ca2+ within a cell is kept very low (~100 nM). When the
cell is stimulated, its Ca2+ concentration is elevated to
approximately 1 μM. While this elevated bulk concentration is sometimes insufficient to activate specific signaling processes, the formation of local hot-spots of Ca2+,
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aka Ca2+ concentration microdomains (CCMs), has been
documented and its concentration can reach tens of micromolar [21]. In our model study, we have used 2 mM
Ca2+ in all experiments to ensure that CaM and chimera
proteins are saturated with Ca2+ for a fair comparison.
Structural change of CaM and chimeras probed with ANS

It is well known that the exposure of the hydrophobic
patches of CaM is essential for target protein recognition.
Such hydrophobic exposure can be photometrically monitored by its interaction with extrinsic 1-anilinonaphthalene
8-sulfonate (ANS) and 2-p-toluidinyl-naphthalene-6sulfonate (TNS) molecules. These two fluorophores have
been widely used as a probe for measuring hydrophobicity.
ANS is a fluorescent dye which emits very weak fluorescence in water due to its excited charge transfer (CT) state
that is quenched easily by water molecules. ANS alone exhibits very little fluorescence with a maximal wavelength
(λmax) of 520 nm (Figure 2). ANS fluorescence increases
dramatically in a hydrophobic environment or when the
rotational motion of its phenylamino group is restricted
[22]. In the absence of Ca2+, the ANS fluorescence of CaM
or chimeras exhibited no change, mainly due to the lack of
hydrophobic surface and the presence of electrostatic repulsion between the negatively charged sulfonate group of
ANS and the negatively charged residues in CaM and chimeras. The fluorescence increased when Ca2+ was included
in the mixture. The ANS intensity showed a 3.01 ± 0.12
fold increase (Table 1; fold increase was determined by the
integration of the whole spectrum and all following values
are referred to in the same manner) and λmax was blue
shifted from 520 to 480 nm in our experimental conditions. This observation is consistent with the fact that the
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Ca2+-bound CaM (Ca2+-CaM) exposes its hydrophobic
surface, followed by ANS binding, in which the proteinbound ANS molecules are more shielded from the solvent.
ANS intensity enhancements were also observed in all
Ca2+-chimeras, with identical concentrations of the
protein and dye, exhibiting increases in fluorescence
ranging from 1.56 - 2.72 fold (Table 1). Our results appear to suggest that the chimeras have less hydrophobic
surface exposure compared with CaM, consistent with
the fact that there is no interaction between TnC and
ANS [13]. However, such a conclusion does not provide
instructive information because it is unclear on
whether the ANS fluorescence enhancements were due
to an increase in ANS lifetime (or quantum yield) and/
or binding affinity. Thus, we turned to study CaM/
chimera ANS binding by using isothermal titration calorimetry (ITC) and lifetime fluorescence.
The raw ITC data for ANS binding to CaM is shown
in Figure 3. The initial ANS injections resulted in heat
released from the complex as shown in a downward heat
rate. The heat evolved is proportional to the amount of
the ANS/Ca2+-CaM complex formation. Apparently, the
titration did not reach completion due to the weak ANS
binding. We fit the data with “one set of sites” to obtain
the apparent association binding constant (Kapp) of 2.10 ±
0.11 × 103 M−1 for Ca2+-CaM (Table 1), consistent with a
previous report [23]. Note that Kapp is not the binding
constant for the ANS molecule; rather it represents the
overall low-affinity interaction of the multiple ANS molecules to CaM. It is unclear on how many ANS binding
sites exist in CaM, given a range of 2–5 ANS molecules in
CaM complexes have been reported [24,25]. Based on our
studies, the middle point from the ITC thermogram (and

Figure 2 ANS fluorescence of uncomplexed and complexed CaM and 3TnC. (A) shows the ANS fluorescence of a solution containing
200 μM ANS and 5 μM CaM in the absence (dotted line) and presence (solid line) of Ca2+. The ANS fluorescence of CaM/Orai-CMBD was
recorded by adding a solution of Orai peptide into Ca2+-CaM until no more intensity change was observed (dashed line). (B) shows the ANS
fluorescence of CaM(3TnC) in the identical experimental condition as in (A). ANS fluorescence was excited at 350 nm.
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Table 1 ANS binding to CaM and chimeras by fluorescence and ITC
ANS binding in the absence of salt

ANS binding in the presence of salt

30 mM Hepes, pH 7.5, 2 mM Ca2+

30 mM Hepes, pH 7.5, 0.1 M NaCl, 2 mM Ca2+ 30 mM Hepes, pH 7.5, 0.1 M NaCl, 2 mM Ca2+

−1

Kapp (M−1)

ANS fold enhancement
(fold)a

Kapp (M−1)

2.10 ± 0.11 × 103 3.49 ± 0.07

3.69 ± 0.08 × 103

3.87 ± 0.10

3.43 ± 0.65 × 103

9.86 ± 1.24 × 102 3.33 ± 0.06

1.13 ± 0.04 × 103

3.31 ± 0.05

1.20 ± 0.08 × 103

3

1.10 ± 0.01 × 10

3.07 ± 0.04

9.70 ± 0.31 × 102

8.56 ± 0.21 × 102

2.24 ± 0.11

1.07 ± 0.10 × 103

3

3.62 ± 0.15

2.67 ± 0.24 × 102

Protein

ANS enhancement Kapp (M )
(fold)a

CaM

3.01 ± 0.12

CaM(1TnC) 2.72 ± 0.10

ANS fold enhancement
(fold)a

3

CaM(2TnC) 2.55 ± 0.05

1.01 ± 0.07 × 10

CaM(3TnC) 1.56 ± 0.04

6.70 ± 0.51 × 102 1.74 ± 0.08

CaM(4TnC) 2.37 ± 0.22

ANS binding in the presence of salt and
Orai-CMBD

3

1.80 ± 0.05 × 10

3.01 ± 0.14

2.90 ± 0.19

2.02 ± 0.03 × 10

a

The ANS intensity enhancements were calculated from spectra integration and compared to the corresponding apo proteins in identical experimental conditions.

the inflection point in the corresponding derived binding
isotherm) indicates approximately 4–6 bound-ANS molecules in Ca2+-CaM. Therefore, Kapp is proportional to the
actual number of protein-bound ANS molecules in the experimental condition. In the text below, we will discuss
Kapp as the ANS binding affinity for simplicity. Almost all
chimera proteins, except CaM(4TnC), showed a significant lower ANS binding affinity, which is parallel to the
findings from fluorescence (Table 1). For example, CaM
(3TnC) has the lowest ANS fluorescent enhancement
(1.56 ± 0.04 fold) and binding constant (6.70 ± 0.51 ×
102 M−1). In the presence of 0.1 M NaCl, both the ANS
fluorescence enhancements and association binding constants for CaM and chimera proteins increased (Table 1),
indicating that the salt screens the repulsion between ANS
and the acidic residues in the proteins. In the absence of

Ca2+, no ANS binding was observed in the ITC experiments, consistent with the fluorescence studies.
Given that steady state fluorescence cannot differentiate the intensity contribution from individual ANS
molecules, we utilized time-correlated single-photon
counting (TCSPC) spectrometry to measure the ANS
fluorescence decay. A solution of 5 μM CaM and 50 μM
ANS in the presence of 2 mM Ca2+ was excited with a
345 nm light source from a NanoLED and the emission
was monitored with a 365 nm cutoff filter. The decay
and the fitted function are shown in Figure 4. The data
was best fit with a three-exponential-decay function.
The shortest lifetime (τ3 = ~0.3 ns) was assigned to that
of free ANS molecules [26], which was confirmed by
using an ANS solution alone. Note that this lifetime
reaches the detection limitation of our instrument and

Figure 3 ANS binding to CaM and CaM(3TnC) by isothermal titration calorimetry. A solution of 50 μM CaM (A) or CaM(3TnC) (B) were
titrated with 5 mM ANS at 25°C in the presence of Ca2+. The ITC data were fit with a “one set of sites” model as described in the Experimental
section. The values from the fitting are shown in Table 1.
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Figure 4 The lifetime measurement of CaM-bound ANS. A
solution containing 5 μM CaM and 50 μM ANS was excited with
345 nm from a NanoLED light source and its dynamic fluorescence
decay (black) was monitored with TCSPC using a 200-ns window for
4000 channels. The prompt is shown in blue color. The decay was
best fitted with a three-exponential decay (green line in upper
panel) and the weighted residues are indicated in the lower panel.
The calculated χ2 is 0.986. The values from the fitting are shown
in Table 2.

therefore, it cannot be determined precisely. Two longer
lifetimes, τ1 = 6.4 and τ2 = 13.1 ns, were only observed in
the presence of Ca2+, thus suggesting two different ANS
populations with rather different probe environments.
The fitting also provided the fractional (or relative amplitude), fs, which weights the “amount” of the emitting
species, and the normalized pre-exponential value, Bs,
which provides the relative concentration of each species. The data for Ca2+-CaM indicates that the τ1 and τ2
species contribute more than 95% (i.e. f1 + f2) to the
fluorescence intensity, but consist of less than 30% of
the total species (i.e. B1 + B2). When decreasing the
[ANS]/[CaM] ratio from 10 to 0.5, the fluorescence intensity is attributed to high “relative concentrations”
of the two longer lifetimes, with f1 = 0.47, B1 = 0.33
and f2 = 0.49, B2 = 0.16. Double fluorescence lifetime of
bound-ANS (or ANS heterogeneity) is commonly seen
in proteins [27] and in molten globular structures
[28], where the later showed that ANS has τ1 = ~2 ns

and τ2 = ~6 ns, in which the short lifetime represents
ANS molecules located on the protein surface, while
the longer lifetime represents ANS in the protein
matrix. The data shown here indicates that the CaMbound ANS molecules are located in a very hydrophobic
environment, limiting its solvent accessibility capacity. In
fact, the Stern-Volmer quenching by acrylamide (see
experimental section) revealed a linear decrease in two
lifetime components, yielding KSV values for the short
and long lifetime (KSV(τ1) and KSV(τ2)) of 1.4 ± 0.2 M−1
and 0.25 ± 0.05 M−1, respectively (data not shown). The
quenching rate constant (kq) for ANS with the short lifetime is 2.2 × 108 M−1 s−1 while kq for τ2 is 1.9 × 107 M−1 s−1,
indicating the later is less solvent accessible. In other
words, the long lifetime component of ANS is one order
less quenched by acrylamide.
It is unclear where the binding sites of the ANS molecules are located in CaM. Using the fragments from the
tryptic cleavage of CaM, it has been suggested that two
ANS molecules bind to the N- and C-terminal lobes
[24]. However, the summation of ANS fluorescence from
individual lobes is much less than that of the intact
CaM. Therefore, we believe that there are multiple ANS
binding sites for CaM, but only two types are distinguishable from each other based on the lifetime measurements. We expected that the interaction of chimeras
and ANS might affect the lifetime and/or its population
(thus contributing to different f values). Such information can not only be used to correlate with steady-state
fluorescence, but also may provide information about
the individual lobes.
The lifetimes of CaM(1TnC)- and CaM(2TnC)-bound
ANS molecules are different to those of CaM, with a
similar τ1 value but substantially larger τ2 value (~18 ns).
The exchanged EFs in the N-terminal lobes appear to reflect a longer ANS lifetime. On the other hand, τ1 for
CaM(3TnC) and CaM(4TnC) is smaller than that of
CaM while their τ2 is similar to that of CaM, indicating
the exchanged EF3 and EF4 have a less profound impact
on the ANS short lifetime component. The average lifetime (<τ>) calculated from Eq. 2 for each chimera is
displayed in Table 2, showing CaM(1TnC) and CaM2

Table 2 ANS lifetimea for the uncomplexed and complexed CaM and chimeras
Without Orai-CMBD

With Orai-CMBD

Component 1

Component 2

Average lifetime (ns)

Component 1

Component 2

τ1 (ns)

f1

τ2 (ns)

f2

<τ>

τ1 (ns)

f1

τ2 (ns)

f2

<τ>

Ca2+-CaM

6.4

0.44

13.1

0.53

9.0

6.8

0.20

16.9

0.66

13.1

Ca2+-CaM(1TnC)

6.2

0.21

17.8

0.70

14.4

6.3

0.31

17.3

0.57

12.7

Ca2+-CaM(2TnC)

5.9

0.20

17.7

0.68

13.7

5.8

0.18

17.3

0.71

12.9

Ca -CaM(3TnC)

4.4

0.29

12.1

0.51

7.4

4.3

0.30

16.2

0.57

11.7

Ca2+-CaM(4TnC)

5.1

0.19

12.9

0.70

8.6

6.0

0.16

17.1

0.72

13.5

2+

a

Data from the fitting are only shown as an average for clarity.

Average lifetime (ns)
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(TnC) have a significant longer ANS average lifetime
(13–14 ns). Though a longer lifetime observed in CaM
(1TnC) and CaM(2TnC) should attribute to a higher
fluorescence intensity, such a contribution is shaded by
the weaker binding as indicated by the ITC studies.
In summary, we observed a correlation between Kapp
values and fluorescence enhancements for ANS binding,
which is on the order of CaM > CaM(1TnC) ~ = CaM
(2TnC) > CaM(3TnC). The lower fluorescence enhancements observed in chimera proteins are dominated by a
lower ANS binding affinity. The lifetime measurements
also revealed ANS heterogeneity. The exchanged EFs
appear to alter ANS lifetimes and fractional values (i.e.
molecule population), with the exchanged EFs in the
N-terminal lobe likely to increase the longer lifetime
component while those in the C-terminal lobe are likely
to slightly decrease the short lifetime component. CaM
(4TnC) is the exception to the trend, with the second
lowest in ANS fluorescence enhancement but the second highest ANS binding affinity. Here, the ANS fluorescence decrease due to the shorter lifetime (5.1 ns) is
compensated by a higher ANS binding affinity (1.80 ±
0.05 × 103 M−1). If ANS fluorescence of a protein truly
reflects the hydrophobic area of the protein, then our
data supports the previous reports that replacing CaM’s
EFs with those of TnC results in a lower ability to expose hydrophobic surface area [13]. However, the extent of hydrophobicity determined from steady-state
ANS fluorescence can be misleading, as it both over
and underestimated ANS binding in the CaM/TnC system determined from ITC.
Fluorescence studies reveal the Ca2+-dependent
interaction between Orai peptide and CaM derivatives

We then studied how CaM and the chimeras interact
with a synthetic 24 amino acid peptide corresponding to
the CaM-binding domain of an Orai channel protein
(Orai-CMBD). Since Orai-CMBD contains a Trp76 residue (numbering in Orai) and there are no Trp residues
in CaM, Trp fluorescence can be used to investigate
the interaction between Orai-CMBD and CaM. The
excitation wavelength at 295 nm was chosen to

eliminate the signal from CaM’s Tyr residues. The peptide alone exhibited low fluorescence with λmax of
350 nm in a Ca2+-independent manner. Upon the
addition of Ca2+-CaM, Trp fluorescence was enhanced
1.82 fold and λmax was blue-shifted from 350 to
335 nm, suggesting that the Trp76 is embedded in a
more hydrophobic environment provided by CaM. In
an identical experiment but without Ca2+, no major
signal change was observed upon the addition of CaM,
supporting the conclusion that the interaction between
Orai and CaM is Ca2+-dependent. The chimera proteins
revealed a similar Trp fluorescence change with the
trend of CaM > CaM(4TnC) = CaM(3TnC) > CaM(1TnC)
> CaM (2TnC) (Table 3). The small difference in intensity
change and λmax suggests Trp76 is bound within the proteins in a similar manner.
The interaction of Orai-CMBD to Ca2+-CaM can also
be monitored using ANS fluorescence. In the absence of
Orai-CMBD, Ca2+-CaM and Ca2+-chimeras interact with
ANS differently with λmax = 480 nm for CaM, CaM
(1TnC), and CaM(2TnC) and λmax = 500 nm for CaM
(3TnC) and CaM(4TnC) (Figure 2). The Orai-CMBD
binding to CaM enhanced ANS fluorescence ~10%,
mainly due to the resulting increases in lifetime (Table 2)
but not affinity (Table 1). Orai-CMBD binding to CaM
retains a similar short ANS lifetime (i.e. 6.4 versus
6.8 ns) but increases the long lifetime from 13.1 to
16.9 ns, respectively (Table 2), whereas Orai-CMBD
binding to CaM(1TnC) and CaM(2TnC) neither increased ANS intensity enhancements, lifetime, and binding affinity. Orai-CMBD binding to CaM(3TnC) and
CaM(4TnC) restored their λmax from 500 to 480 nm and
increased ANS intensities ~30% and 25%, respectively
(Table 1). The fluorescence enhancement was primarily
due to the increase in both lifetime and binding affinity.
Our data revealed that exchanging an EF in the same
lobe (N- or C-terminal) exhibits a similar structural effect probed by the ANS molecule, consistent with the
functional dependency of a tandem EF pair in most EFcontaining proteins.
The non-significant change of ANS lifetimes in the Nterminal ends of CaM(1TnC) and CaM(2TnC) suggests

Table 3 Trp76 of Orai-CMBD fluorescence and Stern-Volmer quenching constants
Protein

λmax (nm)

Trp fluorescence enhancement
upon protein binding (fold)

Ksv (M−1) acrylamide

Ksv (M−1) KI

Orai-CMBD

350

n.a.a

13.5 ± 0.4

13.1 ± 0.5

CaM/Orai-CMBD

335

1.82 ± 0.06

1.35 ± 0.08

1.31 ± 0.08

(CaM)1TnC/Orai-CMBD

335

1.61 ± 0.05

1.80 ± 0.09

1.75 ± 0.06

(CaM)2TnC/Orai-CMBD

336

1.44 ± 0.11

1.95 ± 0.10

1.85 ± 0.05

(CaM)3TnC/Orai-CMBD

336

1.75 ± 0.08

1.32 ± 0.05

1.21 ± 0.09

(CaM)4TnC/Orai-CMBD

337

1.76 ± 0.07

1.51 ± 0.04

1.22 ± 0.10

a

Not applicable.
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that peptide binding causes either minimal conformational change on that lobe or a structural change not
sensitive to the ANS probe. On the other hand, CaM
(3TnC) and CaM(4TnC) have a very similar response to
that of CaM, suggesting the exchanged EFs in the Cterminal end retain their ability of conformational
change for peptide binding.
Thermodynamics and kinetics of Orai-CMBD to CaM and
chimeras

The data from fluorescent studies indicated that the individual exchanged EFs alter the surface hydrophobicity
but retain the binding to Orai-CMBD. However, it is unclear about the specifics of such an interaction. Thus, we
used ITC to obtain the thermodynamics of Orai-CMBD
to CaM and chimeras. The Orai-CMBD titration to
CaM in the presence of Ca2+ at 25°C exhibited a typical
calorimetric reaction (Figure 5A upper panel), in which
the heat release per injection was observed. The heat
evolved decreased gradually till the background signal
was reached. The plot of heat evolved per injection
(ΔQi) versus molar ratio showed an exothermic,
sigmoid-shape binding isotherm (Figure 5A lower panel).
The ITC data was best fit into a “one set of sites” model
and the Ka and ΔH values were determined to be 8.92 ±
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1.03 × 105 M−1 and −5.02 ± 0.13 kcal/mol, respectively,
with N = ~2 (Table 4). The data agreed with the previous
report [20] and the result indicates that CaM contains
two Orai-CMBD binding sites, each with a similar binding affinity and enthalpy change that are not distinguishable with the calorimetric measurement.
The ITC measurements provide information about net
non-covalent interactions, including hydrogen bonds,
ionic interactions, and van der Waals (VDW) interactions, as well as water solvation. However, proton release
or take-up from solvent in the formation of complex
may contribute significantly to the apparent determined
enthalpy (ΔHapp). Therefore, the heat evolved due to
buffer protonation/ionization has to be determined and
corrected to obtain accurate binding information. Using
different buffers, including HEPES, Tris, and POPS, we
found no significant ΔHapp change (data not shown).
Therefore, we concluded that there was no significant
protonation in the CaM/Orai-CMBD complex, in which
the obtained enthalpy difference becomes the binding
enthalpy (ΔHb). We then performed similar experiments
using the chimera proteins. The ITC raw data and
thermogram of CaM(1TnC) and CaM(2TnC) clearly
cannot be interpreted with a “one set of sites” binding
model. It appears that the binding consists of a tighter

Figure 5 The binding thermodynamics of Orai-CMBD to CaM and CaM(1TnC) determined by ITC. A solution of 30 μM CaM (A) or CaM
(1TnC) (B) was titrated with 1 mM Orai-CMBD in 10 mM Tris, pH 7.5, 0.1 M NaCl, 2 mM Ca2+. The upper panels show the heat evolved per
injection and the lower panels show the integrated heat per injection versus the molar ratio. The model for the fitting was “one set of sites” for
CaM and two sequential binding sites for CaM(1TnC). In both cases, the middle points of the thermograms indicates a stoichiometry of 1:2
protein:ligand binding. The values from the fitting are shown in Table 4.
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Table 4 Thermodynamics and kinetics of Orai-CMBD to CaM and chimeras
Protein
CaM

Ka1 (M−1)

ΔH1 (kcal/mol)
5

8.92 ± 1.03 × 10

ΔH2 (kcal/mol)

Binding model or N for one set of sites

koff (s−1)

n.a.

N = 2.05 ± 0.30

1.41 ± 0.08

- 4.99 ± 0.14

1.70 ± 0.30 × 10

- 3.33 ± 0.30

Sequential

2.44 ± 0.21

- 5.21 ± 0.21

1.39 ± 0.35 × 104

- 3.79 ± 0.39

Sequential

2.64 ± 0.32

CaM(3TnC)

5

2.90 ± 0.12 × 10

- 6.58 ± 0.05

n.a.

n.a.

N = 1.93 ± 0.24

0.68 ± 0.25

CaM(4TnC)

5.77 ± 1.35 × 105

- 5.34 ± 0.40

n.a.

n.a.

N = 1.87 ± 0.15

0.72 ± 0.31

CaM(1TnC)

7.57 ± 1.10 × 10

CaM(2TnC)

6.66 ± 0.20 × 105

n.a.

a
4

5

- 5.02 ± 0.13

Ka2 (M−1)

a

Not applicable.

binding with a higher ΔHb followed by a weaker binding
with a lower ΔHb (Figure 5B). The ITC data of CaM
(1TnC) can be best fit with a two sequential binding
mode, yielding Ka1 = 7.57 ± 1.10 × 105 M−1, ΔHb1 = −
4.99 ± 0.14 kcal/mol and Ka2 = 1.70 ± 0.30 × 104 M−1,
ΔHb1 = − 3.33 ± 0.30 kcal/mol. Because Ka1 and ΔHb1
are close to that of CaM, those values are assigned to
Orai-CMBD binding to the C-terminal lobe of CaM
while the lower binding Ka2 and the lower ΔHb2 are associated with the N-terminal lobe of the chimeras. This
conclusion was further supported by the data from CaM
(2TnC), which displayed a similar binding event as CaM
(1TnC). Interestingly, the binding affinity and enthalpy
change for Orai-CMBD complexed with CaM(3TnC)
and CaM(4TnC) are comparable to those of CaM, suggesting that the impact from the exchanged EF3 and EF4
are less important for the binding. On the other hand,
the exchanged EF1 and EF2 resulted in a one-order
weaker binding affinity and a lower enthalpy change. Although it is a challenge to interpret the structural changes
from the obtained thermodynamic parameters, our result
still provides insights for the binding. The negative ΔHb
values presents the non-covalent bond energy for the
complex formation while the positive entropy change, ΔS,
reflects the entropic gain associated with desolvation,
as seen in hydrophobic interactions. For CaM/OraiCMBD, the driving force for the reaction is both
enthalpic and entropic given the negative ΔHb and
positive ΔS (~10 cal/mol·K calculated from ΔG = ΔH –
TΔS and ΔG = − RT ln(Ka) where ΔG is the free energy
change and T is temperature). Our data also suggested
that the exchanged EF1 and EF2 in CaM(1TnC) and
CaM(2TnC) either formed significantly lower noncovalent interactions and/or impaired the side chain
packing and dynamics upon complex formation. It is
very surprising to us that the hydrophobic surface
probed by ANS does not correlate with Orai-CMBD
binding given that CaM(3TnC) had the lowest ANS
fluorescence but a comparable binding to Orai-CMBD.
This contradicts the general concept that the hydrophobicity assessed by ANS reflects the ability of hydrophobic exposure.
To study the kinetics of Orai-CMBD associated or dissociated from CaM, we used a stopped-flow device to

determine the association and dissociation rate constants, kon and koff, respectively. The association was initiated by quickly mixing the Ca2+-CaM and Orai-CMBD
solutions in the presence of Ca2+ and determined by its
fluorescence, excited and monitored at 295 nm and
330 nm, respectively. Like other CaM/CMBD systems,
kon is too fast to be observed [29]. Orai-CMBD release
from Ca2+-CaM was triggered by mixing a solution containing 5 μM dansyl-labeled CaM (dansyl-CaM) and an
excess of Orai-CMBD with a solution containing 75 μM
unlabeled CaM in the presence of Ca2+. The fluorescence of Ca2+-dansyl-CaM has a λmax at 520 nm when
excited at 370 nm. The Orai-CMBD binding resulted in
a fluorescence increase and a λmax blue shift to 490 nm.
In the stopped-flow, the Orai-CMBD release from
dansyl-CaM after mixing was promptly trapped by CaM,
resulting in a dansyl fluorescence decrease (Figure 6A).
The decay was best fit with a single exponential equation, giving koff = 1.41 ± 0.08 s−1 (Table 4). Using the
dansyl-labeled CaM(1TnC) and CaM(2TnC), the koff
values were determined to be 2.44 ± 0.21 and 2.64 ±
0.32 s−1, respectively (Figure 6B and Table 4). The peptide dissociation rates appear to be two-times slower for
CaM(3TnC) and CaM(4TnC) (Figure 6C and Table 4). It
is noteworthy to mention that only a single exponential
decay was observed in all cases. Given that it is generally
accepted that the two lobes of CaM function independently, we expected that either there would be two distinct koff values exhibited for the chimeras if the kinetics
are different for individual lobes, or a single koff value
(as seen in CaM) that reflects the Orai-CMBD dissociation from a specific lobe. It has been reported that the
dansyl-labeling occurs in a single domain of CaM [30]
and it is also suggested that the labeling site is near the
N-terminal lobe [31]. If this is the case, then the obtained koff values presented the Orai-CMBD dissociation
kinetics specifically at the N-terminal lobe. This indicates that the lower ligand binding affinity (i.e. Ka2) seen
in the N-terminal lobe of CaM(1TnC) and CaM(2TnC)
is partly due to the fast ligand dissociation rate. However, such an explanation cannot be applied to CaM
(3TnC) and CaM(4TnC), in which the koff values should
be similar to that of CaM, if assuming an identical
dansyl-labeled site. It is possible that our labeling in the
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Figure 6 Kinetics of Orai-CMBD to CaM and chimeras. A solution of 5 μM dansyl-CaM, dansyl-CaM(1TnC), or dansyl-CaM(3TnC) and 15 μM
Orai-CMBD was quickly mixed with a solution containing 75 μM CaM in the presence of 2 mM Ca2+ and the fluorescence decay was monitored
for 2 s for CaM (A) and CaM(1TnC) (B) and 5 s for CaM(3TnC) (C) (left panel). The decay was fitted with a single exponential decay and the resulting koff
values are shown in Table 4. The peptide dissociated from dansyl-CaM or chimeras from the mixing resulted in the intensity decrease as observed in
the complexed and uncomplexed fluorescently labeled CaM or chimeras (right panel).

exchanged EF3 and EF4 proteins exists within the other
lobe given the very different dansyl fluorescence seen in
CaM(3TnC) and CaM(4TnC). Thus, the slower ligand
dissociation rate may be associated with the C-terminal
lobe.

Circular dichroism to monitor the secondary structure
change upon Orai-CMBD binding

We used circular dichroism (CD) to monitor the secondary structure of Ca2+-CaM upon Orai-CMBD
binding. Ca2+-free CaM showed a shape typical of an
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α-helical structure with a negative peak (ellipticity or θ) at
220 nm and a more profound negative peak 209 nm (data
not shown). In comparison to CaM, no significant difference was seen in all chimera proteins. Ca2+ binding induced a more α-helical formation in CaM and chimeras,
which showed almost equal intensities at 220 and 209 nm.
Because θ220 presents more closely to the α-helical content, whereas θ290 contributes more significantly from the
β sheet and random coil structure, the ellipticity ratio at
these two wavelengths (i.e. θ220/θ209) indicates the secondary structural change relative to the α-helix content. A
perfect helix peptide or a protein with all helix structure
has a θ220/θ209 value of 1.09. Ca2+-CaM contains α-helix
content ranging from 45–60% in solution [32] and crystal
structures [2]. The ellipticity ratio for Ca2+-CaM is ~ 1
due to the contained coil structure that exhibits a large
negative ellipticity at 198 nm and slightly positive ellipticity at 205 nm. The CD spectrum of Ca2+-CaM/
Orai-CMBD shifted to a more negative value at 220
and 209 nm, giving a θ220/θ209 value of 0.89 indicating
significant structural changes for the complex formation. Given that there is no significant change observed in the uncomplexed and complexed CaM [8,9],
the differential spectra (CD of the complex subtracted
from that of Ca2+-CaM) indicates the secondary structure of Orai-CMBD in the complex (dashed line in
Figure 7). The peptide shows a partial helix formation
with θ220/θ209 = 0.71 consistent with the crystal structure.
A similar observation was found for all chimeras, indicating secondary structure similarity among CaM and chimeras in the uncomplexed and complexed forms.

Figure 7 Circular dichroism spectra of uncomplexed and
complexed CaM. The CD spectra of CaM were recorded in the
presence of Ca2+ (solid line) and Ca2+ and Orai-CMBD (dotted line).
Their differential spectrum (dashed line) presents the structure of
Orai-CMBD in the complex assuming no CaM structural change
upon ligand binding. Note that the CD unit was intentionally shown
in degrees of light rotation because the CD spectra of CaM and the
complexed Orai-CBMD have a very similar mean residual ellipticity.
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Stern-Volmer quenching to determine the solvent
accessibility of Trp76

To investigate the microenvironment of Trp76 of OraiCMBD, we employed collision quenching of Trp fluorescence by determining the accessibility of Trp residues to
acrylamide and potassium iodide (KI) for the free and
CaM-bound forms of Orai-CMBD. These two quencher
molecules diffuse differently into the protein pocket and
thus provide different environmental information for
Trp. Fluorescence quenching is the result of Trp either
being translocated to the surface of the protein, or Trp
being located within the protein interior which allows
acrylamide to diffuse. When Trp is being flanked by
positively charged residues, the quenching becomes
more effective with the use of an anionic quencher such
as I−. In the employed conditions, the amounts of CaM
and chimeras were added in excess (based on the molar
ratio determined from ITC) to ensure that there was no
free peptide in the solution. We only observed a linear
quenching curve in Trp quenching at the concentrations
used for acrylamide and KI (Figure 8). Orai-CMBD alone
showed that its Trp residue was greatly accessible for
quenching by acrylamide (Ksv = 13.5 ± 0.4 M−1) and KI
(Ksv = 13.1 ± 0.5 M−1) (Table 3). It is not surprising that
the Ca2+-CaM binding to Orai-CMBD rendered a better
protection against Trp quenching with either acrylamide
(Ksv = 1.35 ± 0.08 M−1) or KI (Ksv = 1.31 ± 0.08 M−1). The
quenching studies were further extended by lifetime

Figure 8 Stern-Volmer plot of Trp76 fluorescence of Orai-CMBD
quenched by acrylamide. A representative figure of Stern-Volmer
quenching by acrylamide is shown for Orai-CMBD and CaM/Orai-CMBD
based on steady state fluorescence. To ensure no free Orai-CMBD
peptide in the complex, CaM or the chimeras were added into the
solution of 5 μM Orai-CMBD until no significant fluorescence change
was observed. The values from the fitting are shown in Table 3. Insert:
the quenching was monitored by two lifetime components of Trp76 of
Orai-CMBD in the complex.
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measurements. The fluorescence decay of Trp in OraiCMBD, excited at 295 nm and monitored by a 325 nm
cutoff filter, was best fit with a three-exponential-decay
function with τ1 = 0.29, τ2 = 3.1 and τ3 = 7.5 ns, which
are consistent to a complex lifetime observed for Trp in
proteins. The addition of Ca2+-CaM to the Orai-CMBD
solution increases the fractions, f2 and f3, for τ2 and τ3
significantly, but no information could be obtained
about binding stoichiometry due to the complex Trp
lifetime. Since the determination for τ1 is within the detection limitation of our TCSPC and its contribution to
the overall fluorescence decay is negligible, we excluded
it from quenching analysis. As shown in the insert of
Figure 8, the τ2 and τ3 components both were quenched,
but to a different extent. The Ksv for the longer lifetime
τ2 (Ksv(τ2)) is 1.52 M−1 and Ksv(τ3) is 0.90 M−1. Since the
steady-state Ksv is between the two Ksv values obtained
from the lifetime measurement, it indicates that the
quenching is a dynamic collision, not a static model.
The lifetime quenching by KI exhibited similar results to
those obtained by acrylamide.
Upon repeating similar studies using the chimera proteins, the Trp fluorescence in the complex with CaM
(1TnC) and CaM(2TnC) was slightly more solvent accessible than CaM, while CaM(3TnC) and CaM(4TnC)
displayed similar quenching values to those of CaM
(Table 3). Interestingly, the Stern-Volmer values obtained from KI are very comparable to those from acrylamide studies, suggesting that the Trp76 of Orai-CMBD
is embedded very deeply in a hydrophobic environment,
such that the size and charged state of the quenchers
cannot be used to differentiate the microenvironment.
Our data aligns with the crystal structure, showing that
Trp76 of Orai-CMBD is surrounded by several hydrophobic residues.
Modeling and solvent-accessible calculations

To rationalize the experimental data on hydrophobic exposure upon Ca2+ binding, we modeled the chimera
structures in the apo- and Ca2+-bound forms by aligning
the sequences of chimeras to the models of apo-CaM
(PDB: 1CFC) and Ca2+-CaM (PDB: 1CLL) as described
in the experimental section, assuming that all chimera
proteins adopt a similar structure to that of CaM. Modeling structures were then subjected to solvent accessible
surface area (ASA) calculations for non-polar area
(ASAnp) and polar area (ASAp) using 1.4 Å as the van
der Waals (VDW) radius and 5 for dot-density. The calculation agrees with conventional thinking in that the
higher hydrophobic surface difference between apo and
holo forms (i.e. ΔASAap) is expected as seen in CaM, in
which the apolar surface increases 555 Å2. However, a
decrease of polar surface difference (ΔASAp), including
those negatively charged residues, of 693 Å2 is also
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expected. Such surface changes are consistent with data
from the ANS studies if one considers that ANSsensitive proteins have to 1) induce more hydrophobic
surface to interact with the aromatic portion of ANS,
and 2) decrease the exposure of negatively charged residues so there becomes less repulsion between ANS sulfonate groups and the acidic protein. We then performed
a similar calculation using the modeled chimera structures, in which the chimera backbone was aligned with
CaM while the orientations of the side chains were optimized. Based on the calculation, there was no strong correlation between the surface exposure and experimental
data as depicted in that of CaM(1TnC) and CaM(2TnC)
having a more positive ΔASAap (733 and 699 Å2) and also
a more negative ΔASAp (−852 Å2 and −861 Å2). Nevertheless, the calculated ΔASAap areas (341 Å2 and 486 Å2)
for CaM(3TnC) and CaM(4TnC) are consistent with the
ANS binding from ITC and fluorescence studies, where
the lower ANS fluorescence was observed. Note that the
extra amino acids in CaM(1TnC) could not be modeled
into the crystal structures and it was assumed that no conformational change upon Ca2+ binding occurred. Thus,
the contribution of this extra sequence was canceled out
in the ΔASA calculation. Similarly, the extra His-tagged
sequence in 3TnC was treated in the same fashion.
Our experimental data suggests that chimera proteins
such as CaM(1TnC) and CaM(2TnC) probably adopt a
different structure than CaM in the N-terminal lobe. In
fact, the structural alignment of CaM (PDB: 1CLL) and
sTnC (4TnC) indicated that both structures cannot be
aligned well given the root-mean square-deviation
(RMSD) value of 6.8181 Å for all atoms. However, if a
specific terminal lobe is aligned, the C-terminus gave
RMSD = 0.856 Å while the N-terminus gave RMSD =
5.2 Å. Thus, it is unlikely that the N-terminal end of the
chimera proteins, such as 1TnC and 2TnC, will adopt a
similar structure as CaM.
The crystal structure of the CaM/Orai-CMBD complex is intriguing because the structure of Ca2+-CaM is
not perturbed after ligand binding. The structural alignment of CaM complexed with Orai-CMBD to Ca2+-CaM
reveals identical structures with RMSD = 0.459 Å. The
experimental characterization in solution, including
ours, all points to the complexation of two Orai-CMBD
molecules that have similar binding affinities and occupy
similar binding environments as judged from Trp76
fluorescence, but can still be differentiated by CaM
(1TnC) and CaM(2TnC).
Rationale of experimental data to the existing crystal
structure of CaM/Orai-CMBD

The CaM/Orai-CMBD complex has been investigated by
crystallography and NMR [20]. X-ray revealed that CaM
adapts an unusual extended conformation with only one
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Orai-CMBD bound in the C-terminal lobe. However,
NMR NOE indicates that CaM-N also interacts with
Orai-CMBD, where both interactions for ligand binding
are primarily hydrophobic. The reported ITC data also
indicated a 1:2 stoichiometry of CaM/Orai-CMBD binding with the Orai-binding to CaM-C four times tighter
(Ka = 9.1 × 105 M−1) than CaM-N (Ka = 2.1 × 105 M−1).
Unambiguous evidence for the stoichiometry determination arose from the study of size exclusion chromatography, in which it showed that CaM is capable of
binding two molecules of thioredoxin-fused OraiCMBD. Therefore, the authors concluded that both the
ligand binding sites of CaM-C and CaM-N are homologous. Our ITC data generally agreed with theirs and the
fitting (“one site of sets” model and N = ~2) indicates
that both binding sites are very similar in terms of thermodynamics. With the exchanged EF1 and EF2, the ITC
thermograms showed a very interesting binding, which
could only be fit with a two-sequential binding sites
model. The results revealed that the N-terminal lobe of
CaM(1TnC) and CaM(2TnC) have a 40 times lower
binding affinity and a lower enthalpy change to OraiCMBD than that of their C-terminal lobe. For a sequential binding, the ligand has to bind the higher affinity
binding site before binding to the lower affinity site. The
basis for this observation is not clear given that two
lobes of CaM are considered to be functionally independent. Thus, our results possibly suggest that CaM
(1TnC) and CaM(2TnC) have an unique structure, in
which conformational change in domains may affect the
central linker region that allows the signal to propagate
from one lobe to the other. In TnC, the movement of

Page 13 of 18

helices that transmits the conformational change over
substantial distances has been cited [33] and thermodynamic evidence supports the cooperativity of both
lobes [34]. This might be particularly applicable to CaM
(2TnC) since there are additional residues located in its
linker region that are believed to alter the binding structure. On the other hand, the exchanged EF3 and EF4
have less profound impact on the Orai-CMBD binding,
displaying a similar binding mode to that of CaM.
In the complex, Orai-CMBD adopts a partial helical
structure in the crystal structure, which is confirmed in
solution by our CD measurements. The Trp76 residue of
Orai-CMBD is deeply buried in a hydrophobic patch
formed by several hydrophobic residues in CaM-N and
CaM-C (Figure 9). The peptide binds to a tunnel formed
with a low-charged surface (gray color in the electrostatic potential map). The negatively-charged surface of
CaM is primarily located near both ends of the peptide.
Based on the crystal and NMR study, CaM/Orai-CMBD
binding appears to be dominated by hydrophobic interactions from Leu73, Trp76, and Leu79 from OraiCMBD with the hydrophobic residues provided from
CaM. The electrostatic interaction formed by residues,
such as Lys and Arg in the CMBD and Glu in CaM, as
seen in other CaM/CMBD systems [1], is essentially not
significant in this system. Those hydrophobic residues
for the interaction in CaM are similar in the chimeras
except for I63V (numbering in CaM) in CaM(2TnC)
and M124I, I125M, V136I, and M144F in CaM(4TnC)
(Figure 10A). The Met substitution to Ile, or vice
versa, has been shown to have very minor effects on
protein structure [35-37]. Similarly, other residue

Figure 9 The proposed model of the 1:2 CaM/Orai-CMBD complex. The coordinates for the proposed model were obtained as a courtesy
from Dr. Birnbaumer. One of two peptides (stick model) forms a partial helix structure and is bound in the hydrophobic patch (primarily gray)
formed by CaM-N, shown as an electrostatic potential surface, where Trp76 (cyan) is deeply buried. The other Orai-CMBD shown in cartoon model
(green) is flanked by the Ca2+-bound (orange) EF-hands in CaM-C.

Jensen et al. BMC Biochemistry (2015) 16:6

Page 14 of 18

Figure 10 The hypothetical interaction of Orai-CMBD to CaM-N and CaM-C. The residues of Leu73, Trp76, and Leu79 are major contributors
to the binding of CaM. In the Trp76 vicinity, the residues in one letter abbreviation in CaM-C are from the crystal structure while those in CaM-N
are a hypothetical prediction (A). The alteration in the position and chimeras are shown in parenthesis. Leu79 is located in the forming helix and
interacts with hydrophobic residues (B). Note that the numbering of residues is one residue off from Figure 1 since the first Met residue is not
included in the crystal structure. We used the same numbering convention as the reference in this figure and within the text for clarity.

substitutions, such as Val and Phe, should retain the
hydrophobic interaction with the ligand, given that the
side chains of CaM are usually dynamic in solution
[38]. Thus, it appears that the C-terminal lobe of the
chimeras is flexible enough to adapt a structure similar
to CaM to facilitate CMBD binding, as suggested by
ANS lifetime fluorescence. On the other hand, the
N-terminal lobe of the chimeras apparently has a different structure to that of CaM (even with only one
residue change in the CMBD binding site of CaM
(2TnC)) and/or is not flexible enough for packing its
side chains for ligand binding, given the lower enthalpy and higher solvent accessible quenching as seen
in ITC and quenching studies. Such results provide an
explanation for the 40 times lower binding affinity
than that of C-terminal lobe. Another key residue for
the complex formation, Leu79, is also embedded into a
hydrophobic surface in CaM-C, whereas CaM(3TnC)
has additional residues substituted, such as V108M,
M109L, and I112T (Figure 10B). The substitution of
Ile with the polar residue Thr appears to have no major
impact for ligand binding. However, the hypothetical
model of CaM-N did not have optimal side chain packing for Leu79 and reorganization of its side chains is

essential for binding. Nevertheless, the hydrophobic
patches for interacting with Trp76 and Leu79 remain
similar for CaM(3TnC) and CaM(4TnC), resulting in a
compatible binding affinity. Apparently, the N-terminal
lobe of CaM(1TnC) and CaM(2TnC) cannot be explained purely by residue substitution as depicted in
modeling studies, suggesting they might adopt a dissimilar structure to that of CaM. The change in structure is
most likely observed on the three dimensional level, rather than that of secondary structure given that CaM
and chimeras have relatively similar extents of secondary
structure in the apo and Ca2+ bound forms as demonstrated by CD.

Conclusions
Here we used the fluorescent dye ANS to probe the
structures of CaM and chimera proteins in the in the absence and presence of Ca2+. ANS studies revealed that
the exchanged EFs alter ANS fluorescence intensity.
However, such an intensity measurement, which is typically interpreted as “hydrophobicity”, should be carefully
explained with the assistance of lifetime and binding affinity studies as described in this report. Lifetime measurements indicated ANS heterogeneity, in which two
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different ANS environments with distinct fluorescence
dynamic decays were observed. Such ANS heterogeneity
is most likely attributed to the two excited levels, which
are altered by the exchanged EFs, especially EF1 and
EF2. Among the chimeras, CaM(3TnC) appears to have
a lower ANS binding affinity. Such a low induced hydrophobicity change might suggest an inability for CMBD
binding. However, thermodynamics of CaM/Orai-CMBD
revealed a poor correlation between ANS fluorescence
and ligand binding, given that CaM(3TnC) still retains a
similar binding affinity as that of CaM. Thus, our data
strongly suggests that the induced hydrophobic surface
assessed from ANS binding does not participate in the
binding to Orai-CMBD. Rather, the determined hydrophobicity most likely reflects the interactions essential
for enzyme activation, separate from CMBD binding. In
fact, this conclusion agrees with the fact that Ca2+-CaM
(3TnC) is not retained on hydrophobic interaction chromatography (HIC), unlike CaM and the other chimeras.
We also used CaM and chimera proteins to investigate
the interaction with Orai-CMBD and rationalize our
data assisted by a published crystal structure. Strictly
speaking, our experimental data also can be explained by
a canonical CaM/CMBD model given that only a single
Orai-CMBD signal was detected in quenching and kinetic studies. However, the ITC data of chimeras clearly
differentiates the two binding sites, thus a single peptide
binding mode observed in some of our studies may be
due to the homologous structures of CaM-C and CaMN, such that average values were obtained. Our experimental data also indicates that the structural models for
CaM(1TnC) and CaM(2TnC) are not reliable, especially
in their N-terminal lobe. Additionally, it is unclear
whether or not the exchanged EFs should have a similar
impact on all CaM/CMBD systems because CaM in the
CaM/Orai-CMBD complex adapts an unusual extended
structure, interacting with the ligand primarily through
hydrophobic forces. Our preliminary data from a collapsed 1:1 CaM/CaMKII model indicated a different observation in response to ANS (unpublished results). Its
ANS fluorescence dropped 1.5 folds and shifted λmax
from 480 to 450 nm upon the complex formation. This
decrease was not due to the change in ANS binding affinity, but rather the shorter lifetime component being
significantly smaller compared with CaM/Orai-CMBD.
Furthermore, one may also anticipate that the exchanged
EF1 and EF2 will result in a similar impact on other
CMBD binding. Our preliminary data has indicated in
some cases the exchanged EF3 and EF4, not EF1 and
EF2, impair the ligand binding. The study here addressed
the first attempt to investigate the relationship of ANSprobed hydrophobicity and its interaction with a CMBD
peptide via spectroscopy, thermodynamic and kinetic approaches. Thus, extensions from this study to other
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known CaM/CMBD systems and to the studies using a
whole target enzyme will help understand the divergence
of structure and function of CaM.

Methods
General

All chemicals were purchased from Sigma-Aldrich (St.
Louis, MO) and Fisher Scientific (Pittsburg, PA), and
were used without further purification. The peptide
with the sequence corresponding to 68–91 residues of
Orai1, H2NEHSMQALSWRKLYLSRAKLKASSRCOOH, was
purchased from NEO BioLab (Cambridge, MA). All
characterization measurements were performed at least
three times using three different protein batches, and the
results were reproducible.
Recombinant protein expression/purification

Chimera proteins, CaM(1TnC), CaM(2TnC), CaM
(3TnC), and CaM(4TnC), were obtained as a generous
gift from Dr. George [39]. CaM and the chimera proteins were expressed and purified as described previously
[14]. In general, bacterial cells carrying the plasmid
containing gene inserts of CaM(1TnC), CaM(2TnC),
and CaM(4TnC) were induced for protein expression by
heat shock at 42°C at an OD600 = ~1.0. The culture was
continuously incubated for an additional 4–6 hrs at
42°C. CaM(3TnC) was sub-cloned to a pLW-His6 vector
and was expressed as described previously for NOX5
[40]. All proteins except CaM(3TnC) were purified
through a phenyl-sepharose column [41]. CaM(3TnC)
was purified through a Ni-NTA column by elution with
40 mM imidazole. The purified proteins were stored at
−80°C until further use. Protein purity was checked on
SDS-PAGE electrophoresis and its purity was estimated
to be > 95% based on density profiles measured using
UN-SCAN-IT software (Silk Scientific, Inc., Utah). The
concentrations of CaM and chimera proteins were determined as reported previously [20]. Dansylation of CaM
and chimeras was performed in the presence of 2 mM
Ca2+ as described previously [30].
Isothermal titration calorimetry

The ITC experiments were carried out on a VP-ITC
(GE, Pittsburgh, PA). Protein samples were bufferexchanged to the desired buffer. Peptide concentration
was prepared by adding buffer to the peptide powder as
measured by weight. All samples were degassed 15–
30 min before loading. To avoid buffer mismatch, the
syringe and sample cells were rinsed with the desired
buffer prior to sample loading. A typical titration was
performed by sequential injections every 120–180 sec of
5–10 μL solution at 25°C. The ITC raw data was corrected for the heat of titrant dilution determined by an
experiment conducted in identical conditions except that
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no protein was contained in the sample cell. The corrected data, after integration of heat evolved, was fitted
with Origin software provided by the manufacturer to
determine Ka and the observed or apparent ΔH (ΔHapp).
For ANS binding, a range of 5–50 μM CaM or chimera
protein was titrated with 2–5 mM ANS solution in
30 mM HEPES, pH 7.5, 2 mM Ca2+, with or without
0.1 M NaCl. The Orai-CMBD binding to the proteins
was determined by titrating a solution of 1 mM OraiCMBD in 10 mM Tris, pH 7.5, 2 mM Ca2+, 0.1 M NaCl
to 30 μM CaM or chimeras.
The possible buffer protonation/ionization to ΔHapp
can be determined using different buffers with the
known values of protonation enthalpy (ΔHi).
ΔHapp ¼ ΔHb þ nΔHi

ð1Þ

where n is the stoichiometry indicating how many protons are released or absorbed to the buffer. A positive
sign of ΔHi indicates a protonation process while a negative denotes a deprotonation process.
Spectroscopic measurements

Absorption measurements were carried out using a UV1800 double-beam spectrometer (Shimadzu, Kyoto, Japan).
The fluorescence spectra were recorded on a FluoroMax3P (Horiba Scientific) equipped with a temperature control
unit. For intrinsic Trp fluorescence, the excitation wavelength of 295 nm was chosen. Note that CaM and chimera
proteins do not contain any Trp residues. The samples
containing ANS or dansyl-labeled proteins were excited at
350 and 370 nm, respectively. The slit widths of 2 and
5 nm were typically chosen for excitation and emission, respectively, to eliminate photobleaching.
The fluorescence lifetime was measured with a TCSPC
DeltaPro fluorometer (Horiba Scientific) at 20°C. For
Trp lifetime measurements, a solution containing 15–
20 μM Orai-CMBD with 5 μM protein was excited at
295 nm from a NanoLED295 source and the emission
was detected with a 325 nm cutoff filter. For ANS lifetime measurements, each sample solution consisted of
5 μM CaM or chimera protein and 50 μM ANS in
30 mM Hepes, pH 7.5, 2 mM Ca2+ or 30 mM Hepes,
pH 7.5, 2 mM Ca2+, 0.1 M NaCl. The lifetimes of free
and bound-ANS were determined separately with the
excitation at 345 nm from a NanoLED350 light source
and the emission with a 365 nm cutoff filter. The decay
distorted by the instrument response was corrected with
a “Prompt” measurement using 0.01% Ludox AS40 colloidal silica (Sigma-Aldrich). The time windows for Trp
and ANS measurements were 100 and 200 ns in 4000
channels with 10,000 peak counts, respectively. The dynamic fluorescence decay was fitted with a multipleexponential decay function as shown in Eq. 2, with the

DAS6 software provided with the instrument. Only
those data with a chi square (χ2) value less than 1.2 were
viewed as acceptable and reported.
IðtÞ ¼ A þ

n
X

αi e−t=τi and f i ¼ αi τ1 =

i¼1

<τ> ¼

n
X

αi τ i 2 =

i¼1

n
X

n
X

αi τ i and

i¼1

αi τ i

i¼1

ð2Þ
where I(t) is the fluorescence intensity at time t, αi represents the pre-exponential factors, fi is the fractional intensity, and < τ > is the amplitude-average lifetime.
The dissociation rate constant of the peptide from
CaM or chimeras was determined by mixing a solution
containing 5 μM dansyl-CaM (or dansyl-labeled chimeras), 15 μM peptide, 2 mM Ca2+ with a solution containing 75 μM CaM and 2 mM Ca2+. The solutions were
excited at 370 nm and the signal changes at 497 nm (or
508 nm for CaM(1TnC) and CaM(2TnC) and 520 nm
for CaM(3TnC) and CaM(4TnC)) were monitored. The
integration and time intervals for all kinetic measurements were 2 and 5 ms, respectively. The fitting was carried out as described previously [41].
Stern-Volmer quenching

The Trp fluorescence quenching of the Orai-CMBD
peptide was carried out at 20°C by adding stock solutions of 6 M acrylamide and 1 M KI to a sample solution
containing CaM and peptide in 50 mM Tris, pH 7.5,
2 mM Ca2+. The concentration of peptide was 5 μM and
the concentrations of proteins ranged from 20 to 40 μM
to ensure no free peptide in the solution. The emission
intensity was recorded at 350 nm for peptide only and at
330 nm for the complex. The following Stern-Volmer
equation was used for fitting:
Fo =F ¼ 1 þ Ksv ½Q

ð3Þ

where F and Fo are the fluorescence intensities at a given
concentration of quencher ([Q]) and in the absence of
quencher, respectively, and Ksv is the dynamic or collisional quenching constant.
For a quenching that is purely by collision, the steadystate and lifetime Stern-Volmer quenching equation can
be expressed as
< τo > = < τ > ¼ 1 þ Ksv ½Q and Ksv ¼ k q x τ0
ð4Þ
where τ and τo are the lifetime in the presence and absence of the quencher, and kq is the quenching rate
constant.
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Far-UV circular dichroism (CD)

The CD spectra were recorded in a JASCO J-715 instrument (JASCO Corporation, Japan) equipped with a
temperature control unit. CD spectra were recorded
using a cylindrical 0.1 cm path length quartz curvet and
were shown as the average of 3–6 scans using a spectra
bandwidth of 1.0 nm. In all measurements, 0.1 mg/ml
proteins in 10 mM Tris, pH 7.5 with 1–2 mM Ca2+ or
0.5 mM EDTA were scanned from 190 nm to 260 nm.
Scans with the Orai-CMBD complexes were performed
in identical conditions, with the addition of 10–12 μM
peptide, calculated based on the molar ratio obtained
from ITC studies.
Modeling

The model structures of chimeras were generated and
optimized with Swiss-Model Automatic Program Modeling Severs (http://swissmodel.expasy.org/) [42,43] using
1CFC and 1CLL as the templates for apo and holo CaM
forms, respectively. The modeling program uses the information from experimentally determined protein
structures to generate a model for a target protein (i.e.
chimera in our case). Briefly, the template (i.e. crystal
structure of CaM) was selected to perform target/template
alignment and the optimization for all-atom models for the
target sequence using ProMol-II [44] or MODELLER [45].
Finally, the model was subjected to a model qualifying
evaluation assigned by the local scoring function QMEAN.
GETAREA was used to calculate solvent accessible surface
areas (http://curie.utmb.edu/getarea.html) [46]. The structures of Orai and chimera proteins were created in the
same manner using the coordinates kindly provided by Dr.
Liu et al. [20]. The electrostatic potentials were calculated
using PyMol with Adaptive Poisson-Boltzmann Solver
(APBS) plugin. First, a Poisson-Boltzmann calculation was
performed using the PARSE force field in the PDB2PQR
server (http://nbcr-222.ucsd.edu/pdb2pqr_1.8/) [47]. The
resulting structure, containing charge and radius information, was used as an input for PyMol calculations. The following parameters were used for the calculation: 0.15 M
for +1 and −1 ions, 310 K, 0.14 Å for solvent radius, and a
dielectric constant of 2 and 78 for the protein and solvent,
respectively.
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